Market Cap 494.40M
Revenue (ttm) 292.50M
Net Income (ttm) -33.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -11.62%
Debt to Equity Ratio 0.00
Volume 632,900
Avg Vol 494,596
Day's Range N/A - N/A
Shares Out 41.20M
Stochastic %K 92%
Beta 0.78
Analysts Strong Sell
Price Target $19.33

Company Profile

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy sy...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 518 795 1400
Address:
14 Plaza Drive, Latham, United States
BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 10:23 PM
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 23 at 6:50 PM
$ANGO $ANIP $ANRO 🔥 Cycle Trading Signal plugged into AI 🔥 You lie they lie but Math don't lie 🔥 keep counting 😉
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 23 at 4:56 PM
$ANGO Outstanding article that hits the mark on ANGO's current state. So if you want to refresh your ANGO insights or learn about ANGO from scratch, this is a must read. https://beyondspx.com/quote/ANGO/analysis/angiodynamics-medtech-momentum-fuels-profitable-growth-trajectory-nasdaq-ango
0 · Reply
SexyStockSlayer
SexyStockSlayer Oct. 22 at 8:21 PM
$ANGO 📰Another insider buy on $ANGO SVP, Chief Legal Officer buys 10,000 shares worth $118,100 https://x.com/sexystockslayer/status/1980982792126382519?s=46&t=5HwCsAVewgyd7U6TGAcZ8w
0 · Reply
SocioCobb
SocioCobb Oct. 22 at 3:33 PM
0 · Reply
SuperCoach
SuperCoach Oct. 16 at 12:45 PM
$ANGO https://time.com/collections/best-inventions-2025/7318433/angiodynamics-nanoknife/
0 · Reply
SuperCoach
SuperCoach Oct. 16 at 12:41 PM
$ANGO 😃👍🏻
0 · Reply
resistancebreakers
resistancebreakers Oct. 16 at 12:22 PM
$DTIL $ANGO 🖥️🪖🫡☝️
0 · Reply
G101SPM
G101SPM Oct. 14 at 4:33 PM
#INSIDERS $ANGO Chief Financial Officer bought 890 shares at $11.16 worth approximately $10K. $ZBIO Director bought 117,255 shares at $19.00 - $20.85 worth approximately $2.X.3 mln pursuant to Securities Purchase Agreement. $CRWV 10% owner Magnetar Financial sold another 414,547 shares of Class A Common Stock worth approximately $61.7 mln
0 · Reply
SexyStockSlayer
SexyStockSlayer Oct. 13 at 10:45 PM
$ANGO SWING IDEA • Consistent earnings beats since Q4 2024 • 4th consecutive Q of over 20% revenue growth • CEO bought $110,000 in shares • AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List • Net Sales, EBITDA, EPS increased • Cashflow positive 2026 https://x.com/SexyStockSlayer/status/1977863102398943369
0 · Reply
Latest News on ANGO
AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call Transcript

Oct 2, 2025, 10:02 AM EDT - 23 days ago

AngioDynamics, Inc. (ANGO) Q1 2026 Earnings Call Transcript


AngioDynamics, Inc. (ANGO) Q4 2025 Earnings Call Transcript

Jul 15, 2025, 12:40 PM EDT - 3 months ago

AngioDynamics, Inc. (ANGO) Q4 2025 Earnings Call Transcript


AngioDynamics, Inc. (ANGO) Q3 2025 Earnings Call Transcript

Apr 2, 2025, 10:20 AM EDT - 7 months ago

AngioDynamics, Inc. (ANGO) Q3 2025 Earnings Call Transcript


AngioDynamics to Host Virtual Cardiovascular Investor Event

Mar 31, 2025, 8:00 AM EDT - 7 months ago

AngioDynamics to Host Virtual Cardiovascular Investor Event


AngioDynamics: A Surgical Approach To Market Growth

Jan 8, 2025, 5:15 PM EST - 10 months ago

AngioDynamics: A Surgical Approach To Market Growth


AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript

Jan 8, 2025, 11:00 AM EST - 10 months ago

AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript


AngioDynamics, Inc. (ANGO) Q1 2025 Earnings Call Transcript

Oct 3, 2024, 10:29 AM EDT - 1 year ago

AngioDynamics, Inc. (ANGO) Q1 2025 Earnings Call Transcript


AngioDynamics to Participate in Upcoming Investor Conferences

Jul 29, 2024, 4:15 PM EDT - 1 year ago

AngioDynamics to Participate in Upcoming Investor Conferences


AngioDynamics: Lumpy Progress Is Still Progress

Jul 17, 2024, 3:16 PM EDT - 1 year ago

AngioDynamics: Lumpy Progress Is Still Progress


AngioDynamics (ANGO) Q4 2024 Earnings Call Transcript

Jul 16, 2024, 10:35 AM EDT - 1 year ago

AngioDynamics (ANGO) Q4 2024 Earnings Call Transcript


A Leaner AngioDynamics Is A High-Risk Execution-Driven Story

Apr 9, 2024, 4:49 PM EDT - 1 year ago

A Leaner AngioDynamics Is A High-Risk Execution-Driven Story


BEATOFtheMARKET
BEATOFtheMARKET Oct. 24 at 10:23 PM
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 23 at 6:50 PM
$ANGO $ANIP $ANRO 🔥 Cycle Trading Signal plugged into AI 🔥 You lie they lie but Math don't lie 🔥 keep counting 😉
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 23 at 4:56 PM
$ANGO Outstanding article that hits the mark on ANGO's current state. So if you want to refresh your ANGO insights or learn about ANGO from scratch, this is a must read. https://beyondspx.com/quote/ANGO/analysis/angiodynamics-medtech-momentum-fuels-profitable-growth-trajectory-nasdaq-ango
0 · Reply
SexyStockSlayer
SexyStockSlayer Oct. 22 at 8:21 PM
$ANGO 📰Another insider buy on $ANGO SVP, Chief Legal Officer buys 10,000 shares worth $118,100 https://x.com/sexystockslayer/status/1980982792126382519?s=46&t=5HwCsAVewgyd7U6TGAcZ8w
0 · Reply
SocioCobb
SocioCobb Oct. 22 at 3:33 PM
0 · Reply
SuperCoach
SuperCoach Oct. 16 at 12:45 PM
$ANGO https://time.com/collections/best-inventions-2025/7318433/angiodynamics-nanoknife/
0 · Reply
SuperCoach
SuperCoach Oct. 16 at 12:41 PM
$ANGO 😃👍🏻
0 · Reply
resistancebreakers
resistancebreakers Oct. 16 at 12:22 PM
$DTIL $ANGO 🖥️🪖🫡☝️
0 · Reply
G101SPM
G101SPM Oct. 14 at 4:33 PM
#INSIDERS $ANGO Chief Financial Officer bought 890 shares at $11.16 worth approximately $10K. $ZBIO Director bought 117,255 shares at $19.00 - $20.85 worth approximately $2.X.3 mln pursuant to Securities Purchase Agreement. $CRWV 10% owner Magnetar Financial sold another 414,547 shares of Class A Common Stock worth approximately $61.7 mln
0 · Reply
SexyStockSlayer
SexyStockSlayer Oct. 13 at 10:45 PM
$ANGO SWING IDEA • Consistent earnings beats since Q4 2024 • 4th consecutive Q of over 20% revenue growth • CEO bought $110,000 in shares • AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List • Net Sales, EBITDA, EPS increased • Cashflow positive 2026 https://x.com/SexyStockSlayer/status/1977863102398943369
0 · Reply
SexyStockSlayer
SexyStockSlayer Oct. 13 at 10:17 PM
$ANGO in at 11.39 DD soon
0 · Reply
SEC_official_Account
SEC_official_Account Oct. 12 at 10:11 PM
$ANGO Gamble 9
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Oct. 10 at 3:15 AM
$ANGO CEO purchased 10,000 shares at $11.15 for a total of $111,500. Clemmer James C now owns 882,529 shares. https://ceo-buys.com
0 · Reply
momyurich
momyurich Oct. 9 at 6:01 PM
$ANGO 📈
0 · Reply
Jigajack1
Jigajack1 Oct. 9 at 12:55 PM
$ANGO strong pre market, hit the support ready for a run at $13.50
0 · Reply
PivotW0lf
PivotW0lf Oct. 6 at 6:20 PM
$ANGO Keep refreshing. NXXT isn’t done yet. It’s just getting cocky. 🦍
0 · Reply
momyurich
momyurich Oct. 6 at 5:36 PM
$ANGO 📈
0 · Reply
Estimize
Estimize Oct. 6 at 2:03 PM
Wall St is expecting -0.10 EPS for $ANGO Q2 [Reporting 01/01 BMO] http://www.estimize.com/intro/ango?chart=historical&metric_name=eps&utm_c
0 · Reply
DARKP00L
DARKP00L Oct. 3 at 2:21 PM
$ANGO 10:01 on Oct. 03 2025 Canaccord Genuity Maintains Buy on AngioDynamics, Raises Price Target to $18 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Oct. 3 at 2:01 PM
Canaccord Genuity updates rating for AngioDynamics ( $ANGO ) to Buy, target set at 17 → 18.
0 · Reply
ZacksResearch
ZacksResearch Oct. 3 at 12:27 PM
$ANGO posts a narrower-than-expected loss — bullish signs ahead? 🔍 💰 Adjusted loss per share of 10 cents beat the Zacks Consensus Estimate of 14 cents. 📈 Pro-forma revenue jumped 12.2% on a reported basis, with Med Tech sales increasing 26%. Discover what this means for ANGO's FY26 outlook here 👉 https://www.zacks.com/stock/news/2761304/ango-stock-gains-following-q1-earnings-beat-gross-margin-improves?cid=sm-stocktwits-2-2761304-body-14575&ADID=SYND_STOCKTWITS_TWEET_2_2761304_BODY_14575
0 · Reply
ZacksResearch
ZacksResearch Oct. 3 at 11:27 AM
$ANGO pops after Q1 surprise 🚀 Narrower-than-expected loss, 12% revenue growth, and improved margins — plus a raised FY26 sales outlook — lit a fire under the stock. Full breakdown here 👉 https://www.zacks.com/stock/news/2761304/ango-stock-gains-following-q1-earnings-beat-gross-margin-improves?cid=sm-stocktwits-2-2761304-teaser-14574&ADID=SYND_STOCKTWITS_TWEET_2_2761304_TEASER_14574
0 · Reply